elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Institutions
beta
Research Intelligence
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Clastogen
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Clastogen
RIS
0.000
(Research Intensity Score)
Papers
47
Top papers
Current understanding of hexavalent chromium [Cr(VI)] neurotoxicity and new perspectives
2021 · 342 citations
A Systematic Genotoxicity Assessment of a Suite of Metal Oxide Nanoparticles Reveals Their DNA Damaging and Clastogenic Potential
2024 · 31 citations
Arsenic methylation – Lessons from three decades of research
2021 · 62 citations
Assessment of Genotoxicity of Zinc Oxide Nanoparticles Using Mosquito as Test Model
2023 · 16 citations
Low-dose toxicity of biogenic silver nanoparticles fabricated by Swertia chirata on root tips and flower buds of Allium cepa
2017 · 124 citations
Newest papers
Toxicological and Cytogenetic Screening of Strontium Ranelate Alone and in Combination With Resveratrol
2026
A Systematic Genotoxicity Assessment of a Suite of Metal Oxide Nanoparticles Reveals Their DNA Damaging and Clastogenic Potential
2024 · 31 citations
Assessment of Genotoxicity of Zinc Oxide Nanoparticles Using Mosquito as Test Model
2023 · 16 citations
Current understanding of hexavalent chromium [Cr(VI)] neurotoxicity and new perspectives
2021 · 342 citations
Arsenic methylation – Lessons from three decades of research
2021 · 62 citations
A sample from the 47 top papers behind Clastogen.
Create a free account to browse them all →
Clastogen's history
Research intensity over time
Explore Clastogen's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Clastogen's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link